Non Surgical Management of Cholelithyasis (Pittashmari): A Case Study
DOI:
https://doi.org/10.22270/ajprd.v7i1.443Keywords:
Cholelithiasis, cholecystectomy,pittashmari, herbal medicineAbstract
As a matter of fact, surgery (cholecystectomy or gall bladder removal) is the most common form of treatment for cholelithiasis (gallstones). However, the fact that surgically removing gallstones requires the removal of an entire organ has led to a growing interest in non-surgical treatments for gallstones. Besides alleviating symptoms, treatment for gallstones is necessary to avoid a progression that can result in severe conditions such as acute cholelithiasis. But so far as the medical management of cholelithiasis is concerned, it is not up to the mark in modern healing system. Although ursodiol or chenodiol in the form of oral bile acid pills, extracorporeal shock-wave lithotripsy (ESWL), contact dissolution therapy [injecting a solvent known a Methyl tertiary-butyl ether (MTBE) into the gallbladder to dissolve the gallstones], Percutaneous Cholecystostomy are good non-surgical measures, their roles are either limited or these are not free from adverse effects. Obviously, there is an urgent need of help from Alternative therapy to counter these difficulties. This article is a step in the direction of making an availability of a safe and effective non-surgical management of cholelithiasis to the ailing mankind.
Downloads
References
2. Kim IS, Myung SJ, Lee SS, Lee SK, Kim MH. "Classification and nomenclature of gallstones revisited". Yonsei Medical Journal, 2003; 44(4): 561–70.
3. Attili AF, Capocaccia R, Carulli N et al. Factors associatedwith gallstone disease in the MICOL experience. Multi center Italian Study on Epidemiology of Cholelithiasis. Hepatology1997; 26: 809–18.
4. Stampfer MJ, Maclure KM, Colditz GA, Manson JE, WillettWC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 1992; 55: 652–8
5. Amaral JF, Thompson WR. Gallbladder disease in the morbidlyobese. Am J Surg 1985; 149: 551–7.
6. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415–28.
7. Ahlberg J, Angelin B, Einarsson K, Hellstrom K, Leijd B. Prevalence of gallbladder disease in hyperlipoproteinemia. Dig Dis Sci 1979; 24: 459–64
8. Einarsson K, Hellstrom K, Kallner M. Gallbladder disease in hyperlipoproteinaemia. Lancet 1975; 1: 484–7.
9. Einarsson K, Hellstrom K, Kallner M. Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyper lipoproteinemia. J Clin Invest 1974; 54: 1301–11.
10. Nervi F, Miquel JF, Alvarez M et al. Gallbladder disease is associated with insulin resistance in a high risk Hispanic population. JHepatol 2006; 45: 299–305.
11. Scragg RK, Calvert GD, Oliver JR. Plasma lipids and insulin in gall stone disease: a case-control study. Br Med J (Clin Res Ed) 1984; 289: 521–5.
12. Grundy SM. Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr 2004; 80: 1–2
13. Scragg RK, McMichael AJ, Seamark RF. Oral contraceptives, pregnancy, and endogenous estrogen in gall stone disease–a case-control study. Br Med J (Clin Res Ed) 1984; 288: 1795–9.
14. Henriksson P, Einarsson K, Eriksson A, Kelter U, Angelin B. Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatmentof prostatic carcinoma. J Clin Invest 1989; 84: 811–6.
15. Angelin B, Olivecrona H, Reihner E et al. Hepatic cholesterol metabolism in estrogen-treated men. Gastroenterology 1992;103: 1657–63.
16. Lee DW, Gilmore CJ, Bonorris G et al. Effect of dietary cholesterolon biliary lipids in patients with gallstones and normal subjects. Am J ClinNutr 1985; 42: 414–20.
17. Scragg RK, McMichael AJ, Baghurst PA. Diet, alcohol, andrelative weight in gall stone disease: a case-control study. BrMed J (Clin Res Ed) 1984; 288: 1113–9.
18. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Glycemic load, glycemic index, and carbohydrate intake in relation to risk of cholecystec tomy in women. Gastroenterology 2005; 129; 105–12.
19. Nervi F, Covarrubias C, Bravo P et al. Influence of legumeintake on biliary lipids and cholesterol saturation in young Chilean men. Identification of a dietary risk factor for cholesterolgallstone formation in a highly prevalent area. Gastroenterology 1989; 96: 825–30.
20. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men: a prospective cohort study. Ann Intern Med 2004; 141: 514–22.
21. Leitzmann MF, Willett WC, Rimm EB et al. A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men.JAMA 1999; 281: 2106–12.
22. Leitzmann MF, Giovannucci EL, Stampfer MJ et al. Prospective study of alcohol consumption patterns in relation to symptomatic gallstone disease in men. Alcohol ClinExp Res 1999;23: 835–41.
23. Leitzmann MF, Giovannucci EL, Rimm EB et al. The relationof physical activity to risk for symptomatic gallstone diseasein men. Ann Intern Med 1998; 128: 417–25.
24. Leitzmann MF, Rimm EB, Willett WC et al. Recreational physical activity and the risk of cholecystectomy in women.NEngl J Med 1999; 341: 777–84.
25. Liddle RA, Goldstein RB, Saxton J. Gallstone formation during weight-reduction dieting. Arch Intern Med 1989; 149:1750–3.
26. Gustafsson U, Benthin L, Granstrom L, Groen AK, Sahlin S, Einarsson C. Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatricsurgery. Hepatology 2005; 41: 1322–8.
27. Syngal S, Coakley EH, Willett WC, Byers T, Williamson DF,Colditz GA. Long-term weight patterns and risk for cholecystectomyin women. Ann Intern Med 1999; 130: 471–7.
28. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Weight cycling and risk of gallstone disease in men. Arch Intern med 2006; 166: 2369–74.
29. Weinsier RL, Wilson LJ, Lee J. Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk ofgallstone formation. Am J Med 1995; 98: 115–7.
30. Angelin B, Einarsson K, Leijd B. Clofibrate treatment and bilecholesterol saturation: short-term and long-term effects andinfluence of combination with chenodeoxycholic acid. Eur J Clin Invest 1981; 11: 185–9.
31. Angelin B, Einarsson K, Leijd B, Biliary lipid composition during treatment with different hypolipidaemic drugs. EurJClin Invest 1979; 9: 185–90.
32. Grundy SM, Vega GL. Fibric acids: effects on lipids and lipoprotein metabolism. Am J Med 1987; 83: 9–20.
33. Experimental investigation of the flow of bile in patient specific cystic duct models M Al-Atabi, SB Chin… - Journal of biomechanical engineering 2010.
34. National Health Service. "Gallstones—Treatment". NHS Choices: Health A-Z - Conditions and treatments. London: National Health Service, 2010.
35. Jensen. "Postcholecystectomy syndrome". Omaha, Nebraska: Medscape (WebMD), 2010.
36. Marks, Janet; Shuster, Sam; Watson, A. J. "Small-bowel changes in dermatitis herpetiformis". The Lancet, 1966; 288(7476): 1280–2.
37. Database of Systematic Reviews (4): CD006231. National Institute of Diabetes and Digestive and Kidney Diseases2007."Gallstones" . Bethesda, Maryland:National Digestive Diseases Information Clearinghouse, National Institutes of Health, United States Department of Health and Human Services. Retrieved 2011.
38. Keus, Frederik; de Jong, Jeroen; Gooszen, H G; Laarhoven, C JHM; Keus, Frederik. "Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis".Cochrane2006.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.